166 related articles for article (PubMed ID: 33185527)
21. Randomised controlled trial: Can topical timolol maleate prevent complications for small superficial infantile haemangiomata in high-risk areas?
Cheng JWCH; Lam YY; Fung GPG; Sin C; Luk DCK; Chan BHB; Chiu WK
Pediatr Res; 2020 Nov; 88(5):756-760. PubMed ID: 32357362
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas.
Gong H; Xu DP; Li YX; Cheng C; Li G; Wang XK
Br J Oral Maxillofac Surg; 2015 Nov; 53(9):836-40. PubMed ID: 26427968
[TBL] [Abstract][Full Text] [Related]
23. Topical timolol maleate for superficial infantile hemangiomas: an observational study.
Xu DP; Cao RY; Tong S; Xue L; Sun NN; Wang XK
J Oral Maxillofac Surg; 2015 Jun; 73(6):1089-94. PubMed ID: 25843815
[TBL] [Abstract][Full Text] [Related]
24. A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.
Jiang C; Hu X; Ma G; Chen D; Jin Y; Chen H; Chen X; Lin X
Pediatr Dermatol; 2011; 28(3):259-66. PubMed ID: 21615472
[TBL] [Abstract][Full Text] [Related]
25. Infantile haemangioma: topical timolol gel may be safer in premature babies.
Paul SP; Davis RF
Br J Hosp Med (Lond); 2019 Aug; 80(8):i. PubMed ID: 31437034
[No Abstract] [Full Text] [Related]
26. Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas.
Ng MSY; Tay YK; Ng SS; Foong AYW; Koh MJ
Pediatr Dermatol; 2017 Jul; 34(4):492-493. PubMed ID: 28543755
[TBL] [Abstract][Full Text] [Related]
27. A controlled study of topical 0.25% timolol maleate gel for the treatment of cutaneous infantile capillary hemangiomas.
Chambers CB; Katowitz WR; Katowitz JA; Binenbaum G
Ophthalmic Plast Reconstr Surg; 2012; 28(2):103-6. PubMed ID: 22410658
[TBL] [Abstract][Full Text] [Related]
28. Topical timolol for small hemangiomas of infancy.
Moehrle M; Léauté-Labrèze C; Schmidt V; Röcken M; Poets CF; Goelz R
Pediatr Dermatol; 2013; 30(2):245-9. PubMed ID: 22471694
[TBL] [Abstract][Full Text] [Related]
29. Topical timolol treatment for periocular infantile haemangioma in the developing world.
Jefferson RJ; Hildebrand GD
Trop Doct; 2019 Jul; 49(3):246-248. PubMed ID: 31014195
[TBL] [Abstract][Full Text] [Related]
30. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
Ge J; Zheng J; Zhang L; Yuan W; Zhao H
Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
[TBL] [Abstract][Full Text] [Related]
31. Experience with topical timolol maleate for the treatment of ulcerated infantile hemangiomas (IH).
Boos MD; Castelo-Soccio L
J Am Acad Dermatol; 2016 Mar; 74(3):567-70. PubMed ID: 26892656
[No Abstract] [Full Text] [Related]
32. Topical Timolol for Infantile Haemangioma of the Orbit.
Hildebrand GD; Sipkova Z
Klin Monbl Augenheilkd; 2021 Oct; 238(10):1069-1076. PubMed ID: 34662921
[TBL] [Abstract][Full Text] [Related]
33. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study.
Chakkittakandiyil A; Phillips R; Frieden IJ; Siegfried E; Lara-Corrales I; Lam J; Bergmann J; Bekhor P; Poorsattar S; Pope E
Pediatr Dermatol; 2012; 29(1):28-31. PubMed ID: 22150436
[TBL] [Abstract][Full Text] [Related]
34. Topical timolol for small infantile hemangioma: a new therapy option.
Weissenstein A; Straeter A; Villalon G; Bittmann S
Turk J Pediatr; 2012; 54(2):156-8. PubMed ID: 22734302
[TBL] [Abstract][Full Text] [Related]
35. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas.
Sorrell J; Chamlin SL
Pediatr Dermatol; 2013; 30(5):592-4. PubMed ID: 23889228
[TBL] [Abstract][Full Text] [Related]
36. Spectral Doppler ultrasound for predicting long-term response to topical timolol in children with infantile hemangioma.
He L; Huang G
J Clin Ultrasound; 2017 Oct; 45(8):480-487. PubMed ID: 28369943
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the efficacy between topical timolol and pulsed dye laser in the treatment of ulcerated infantile haemangiomas: a randomized controlled study.
Chen QY; Chang L; Qiu YJ; Ying HR; Chang SJ; Zhang Y; Chen ZA; Ma G; Lin XX
J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):e303-e305. PubMed ID: 33289216
[No Abstract] [Full Text] [Related]
38. Topical Timolol for Infantile Hemangiomas: Evidence for Efficacy and Degree of Systemic Absorption.
Weibel L; Barysch MJ; Scheer HS; Königs I; Neuhaus K; Schiestl C; Rentsch K; Müller DM; Theiler M
Pediatr Dermatol; 2016; 33(2):184-90. PubMed ID: 26840644
[TBL] [Abstract][Full Text] [Related]
39. Topical timolol for infantile hemangiomas: putting a note of caution in "cautiously optimistic".
McMahon P; Oza V; Frieden IJ
Pediatr Dermatol; 2012; 29(1):127-30. PubMed ID: 22256996
[No Abstract] [Full Text] [Related]
40. Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases.
Danarti R; Ariwibowo L; Radiono S; Budiyanto A
Dermatology; 2016; 232(5):566-571. PubMed ID: 27592104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
